951
Participants
Start Date
November 30, 2007
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
fesoterodine fumarate
8mg tablets OD for 12 weeks
Placebo
Corresponding placebo tablets OD for 12 weeks
fesoterodine fumarate
4mg tablets OD for 12 weeks
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Taichung
Pfizer Investigational Site, Chiayi Country
Pfizer Investigational Site, Koahsiung
Pfizer Investigational Site, Hualien City
Pfizer Investigational Site, Kowloon
Pfizer Investigational Site, Shatin
Pfizer Investigational Site, Nagoya
Pfizer Investigational Site, Chuo-ku, Chiba-shi
Pfizer Investigational Site, Eiheiji-cyo,yoshida-gun,
Pfizer Investigational Site, Fukuoka
Pfizer Investigational Site, Koga-shi
Pfizer Investigational Site, Minami-ku, Fukuoka-shi
Pfizer Investigational Site, Nishiku
Pfizer Investigational Site, Sawara-ku
Pfizer Investigational Site, Amagasaki-shi
Pfizer Investigational Site, Higashinada
Pfizer Investigational Site, Nada-ku, Kobe-shi
Pfizer Investigational Site, Suma-ku, Kobe-shi
Pfizer Investigational Site, Takaraduka-city
Pfizer Investigational Site, Aira-gun, Aira-chou,
Pfizer Investigational Site, Isogo-ku, Yokohama-shi
Pfizer Investigational Site, Kawasakishi
Pfizer Investigational Site, Sagamihara-shi
Pfizer Investigational Site, Tama-ku, Kawasaki-shi
Pfizer Investigational Site, Kochi
Pfizer Investigational Site, Kumamoto
Pfizer Investigational Site, Tamana-shi
Pfizer Investigational Site, Matsumoto-shi
Pfizer Investigational Site, Matumoto-Shi
Pfizer Investigational Site, Hunaki-cho, Ibaraki-shi
Pfizer Investigational Site, Kita-ku, Osaka-shi
Pfizer Investigational Site, Kosobe-cho, Takatsuki-shi
Pfizer Investigational Site, Minami-ku, Sakai-shi
Pfizer Investigational Site, Nishinari-ku
Pfizer Investigational Site, Osaka
Pfizer Investigational Site, Suita-shi,
Pfizer Investigational Site, Suita-shi
Pfizer Investigational Site, Toyonaka
Pfizer Investigational Site, Yodogawa-Ku
Pfizer Investigational Site, Saitama-shi
Pfizer Investigational Site, Satte-shi
Pfizer Investigational Site, Wakou-shi
Pfizer Investigational Site, Gotenbashi
Pfizer Investigational Site, Susono
Pfizer Investigational Site, Bunkyo-ku
Pfizer Investigational Site, Chofu-shi
Pfizer Investigational Site, Chuo-ku
Pfizer Investigational Site, Fucyushi
Pfizer Investigational Site, Koto-ku
Pfizer Investigational Site, Nakano-ku
Pfizer Investigational Site, Nishi-Tokyo-shi
Pfizer Investigational Site, Setagaya-ku
Pfizer Investigational Site, Setgaya-ku
Pfizer Investigational Site, Shibuya-ku
Pfizer Investigational Site, Shinjuku-ku
Pfizer Investigational Site, Suginami-ku
Pfizer Investigational Site, Sumida-ku
Pfizer Investigational Site, Chuou-shi
Pfizer Investigational Site, Cheonan-si
Pfizer Investigational Site, Pusan
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY